Year: 2019
Type: article
Abstract: Bariatric surgery including Roux-en-Y gastric bypass, sleeve gastrectomy, and adjustable gastric band may play a role in glycemic control by improving insulin secretion and sensitivity, specifically through improvement in the main incretin hormones known as glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). These surgical interventions have been shown to provide effective long-term treatment for patients by providing durable weight loss, improving obesity-related comorbidities and fostering better health outcomes. Achieving glycosylated hemoglobin levels below 7% can be very challenging in obese diabetic patients. Therefore, the effect of bariatric surgery compared to standard medical therapy alone in attaining this goal and thus improving health-related outcomes in these patients needs examination. To explore this treatment approach, medical literature on bariatric surgery, obesity and type 2 diabetes mellitus, including the impact of these surgical interventions on patients’ overall health, were reviewed.
Author: Dike, Nwanneka
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6981420156